| Date Filed | Type | Description |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 06/12/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 03/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/03/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
8-K
| Quarterly results |
| 01/17/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/20/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 09/23/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 09/20/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/07/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 09/07/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/19/2022 |
8-K
| Quarterly results |
| 06/23/2022 |
8-K
| Quarterly results |
| 06/10/2022 |
8-K
| Quarterly results |
| 06/03/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/29/2022 |
8-K
| Quarterly results |
| 04/01/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 04/01/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 02/24/2022 |
8-K
| Quarterly results |
| 01/05/2022 |
5
| Thom Brian David (Director) has filed a Form 5 on United Health Products, Inc. |
| 01/04/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 12/10/2021 |
8-K
| Quarterly results |
| 11/05/2021 |
5
| BEPLATE DOUGLAS K (10% Owner) has filed a Form 5 on United Health Products, Inc. |
| 10/14/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data|
Docs:
|
"United Health Products Provides Business Update Henderson, Nevada – October 7, 2021 – United Health Products, Inc. , , developer, manufacturer and marketer of HemoStyp™, a patented Neutralized Oxidized Regenerated Cellulose hemostatic agent, today provided an update on its regulatory approval application process and other business activities. As part of its substantive review process to evaluate UHP’s PMA application, the FDA has requested details on certain elements of the HemoStyp manufacturing process. In keeping with industry best practices, UHP recently completed the implementation of an industry standard Good Manufacturing Practices software tool and will be submitting a response to the FDA’s request later this month. Separately, UHP’s registration statement was declared effect...",
"Investor Presentation" |
|
| 09/30/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/28/2021 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 08/16/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 06/29/2021 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 06/28/2021 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
| 05/12/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
|